Benjamin Reardon and Emmanuel J Favaloro/LinkedIn
Feb 5, 2026, 16:20
Emmanuel J Favaloro: New Study on Biomarkers for Coagulation Disorders
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Biomolecules (MDPI):
“Latest publication from the Sydney Centres for Thrombosis and Haemostasis. Again ably led by Ben Reardon. Biomarkers of Coagulation Disorders.”
Title: Biomarkers of Coagulation Disorders—Where to from Here?
Authors: Benjamin Reardon, Leonardo Pasalic, Emmanuel J. Favaloro
Read the Full Article on Biomolecules (MDPI)
Find more posts featuring Emmanuel J Favaloro on Hemostasis Today.
-
May 12, 2026, 11:13Matteo Foschi: Grateful To Be Selected for The WSO Future Stroke Leaders Programme
-
May 12, 2026, 11:05Omid Seidizadeh: Strategies to Guide The 2nd 100 years of VWD Care and Research
-
May 12, 2026, 11:01Kate Scrivener: The Big Picture of Exercise Trials to Prevent Falls After Stroke
-
May 12, 2026, 10:39Rucha Patil: Our ”Factor VIII Inhibitor Point-of-Care Diagnostic” Is Successfully Transferred at Science-Tech
-
May 12, 2026, 10:26Fabrice Cognasse: The EFS Is First and Foremost Part of a Medical Discipline – Transfusion
-
May 11, 2026, 16:52Luke McLaughlin: Raising Awareness on Haemophilia Issues at ENIL Lead On
-
May 11, 2026, 16:49Jeff Sternlicht: Normal LDL Does Not Always Mean Low Risk
-
May 11, 2026, 16:42Archil Jaliashvili: From Managing Blood to Managing Oxygen Metabolism
-
May 11, 2026, 16:42Heghine Khachatryan: Celebrating One Hundred Years of von Willebrand Disease with EHC